|
|
Volumn 71, Issue 156 S, 1992, Pages 5-8
|
|
Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate
|
|
Author keywords
androgenicity; glucose metabolism; lipids; Norgesrimate
|
|
Indexed keywords
CARBOHYDRATE;
DRUG DERIVATIVE;
ETHINYLESTRADIOL;
INSULIN;
LIPID;
NORGESTIMATE;
NORGESTREL;
ORAL CONTRACEPTIVE AGENT;
ANDROGEN;
ETHINYLESTRADIOL PLUS NORGESTIMATE;
GLUCOSE;
GLYCOSYLATED HEMOGLOBIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TRI CILEST;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
ARTICLE;
BLOOD;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
METABOLISM;
CHOLESTEROL BLOOD LEVEL;
DIET RESTRICTION;
GLUCOSE METABOLISM;
HUMAN EXPERIMENT;
INSULIN BLOOD LEVEL;
MAJOR CLINICAL STUDY;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
ADOLESCENT;
ADULT;
BLOOD GLUCOSE;
CARBOHYDRATES;
CONTRACEPTIVES, ORAL, COMBINED;
ETHINYL ESTRADIOL;
FEMALE;
HUMAN;
INSULIN;
LIPIDS;
NORGESTREL;
|
|
EID: 0026786829
PISSN: 00016349
EISSN: 16000412
Source Type: Journal
DOI: 10.3109/00016349209156508 Document Type: Article |
|
Times cited : (28)
|
|
References (11)
|
